Prize-winner

2016 prize-winner: Jonas OGIEN

Jonas OGIEN Jonas OGIEN has been named the 9th winner of SILAB – Jean PAUFIQUE Corporate Foundation.
The project chosen focuses on « Microscopy by high-resolution, augmented-contrast optical coherence for non-invasive diagnosis of skin cancer ». His research will be carried out at the Charly Fabry Laboratory in Palaiseau, part of the Optical Institute Graduate School, under the supervision of Arnaud Dubois, Professor in charge of the « Biomedical Imaging Systems » team. The objective of the project is to develop an optical imaging system with the capacity to produce similar images to the histological images currently used to diagnose skin cancer, in an non-invasive way (without a biopsy) and in real time. Additional imaging methods (angiography and polarimetry) will also be included in the system to improve the sensitivity and specificity of the diagnosis of early-stage tumors.

 

Previous prize-winner

Laure GIBOT

2015 prize-winner: Laure GIBOT

The project that was selected is dedicated to « Electroporation associated to calcium to treat melanoma ». The research works are carried out in the Institute of Phamacology and Structural Biology in Toulouse, within the Marie-Pierre ROLS team, research director in charge of the Cellular Biophysical team.
Research is organized around the use of calcium (better safety profile, easily accessible and inexpensive) as a substitute for conventional anticancer drugs. The results could be useful to determine if the electroporation associated to calcium can become a treatment of interest in the fight against melanoma, both in industrialized countries and in developing ones.


Laura CAU

2014 prize-winner: Laura CAU

The research project that was retained is dedicated to « Importance of the desimination in the epidermal homeostasis ».
The works are carried out in the UDEAR-CNRS unit, University of Toulouse, in the Dr Michel SIMON team who is known worldwide as specialist of the desimination study in the skin, and conducted by Pr Guy SERRE. Dr Michel SIMON and Pr Hidenari TAKAHARA, University of Ibaraki in Japan, are the co-directors of this project.
Research is organized around the importance of peptidyl-arginine desiminases (PADs) in the epidermal homeostasis. The work will be able to determine if PADs is involved in atopic dermatitis and/or psoriasis. The results obtained could be useful to better understand the implication of PADs in the carcinogenesis.


Carmelo LUCI

2013 prize-winner: Yann CHELI

The research project that was retained is dedicated to "Methylation of histones and melanoma initiating cells (MIC): towards a new therapeutic approach."
The works are carried out at the Mediterranean Centre for Molecular Health (C3M - Centre Méditerranéen de Médecine Moléculaire), INSERM U1065 team 1 in Nice, in the laboratory "Biology and pathology of melanocytic cells: from skin pigmentation to melanomas," conducted by Dr. Robert BALLOTTI.
Research is organized around the study of the role of histones methylation in the mechanisms of gene regulation of stem cells in the tumor cells, validation as potential biomarkers in the progression of the disease as well as the determination of possible new therapeutic targets.


Laetitia DOUGUET

2012 prize-winner: Laëtitia DOUGUET

The research project is entitled "The prognostic value of myeloid cells in skin melanoma and myeloid infiltrate modeling in response to chemotherapy".
The research work is conducted within the Cochin Institute in Paris, INSERM U1016, in the immunohematology department, within the team "Study of the immune response and its regulation in melanoma", under the direction of Ph.D Armelle PRÉVOST-BLONDEL.
The focus of the research is the study of interactions between the immune system and melanoma cells, as well as the assessment of the impact of chemotherapy and new biotherapies on the immune environment.


Carmelo LUCI

2011 prize-winner: Carmelo LUCI

Ph.D in molecular and cellular aspects in biology
The research project of the laboratory is entitled "Cutaneous carcinomas and immunity system: stimulation of the anti-tumor properties of the natural killer cells and dendritic cells"..
The research work is conducted within the Institute of Molecular Pharmacology - UMR 6097, at the University of Nice Sophia-Antipolis, in the team "regulation of immune responses to muco-cutaneous sites" under the joint supervision of PhD Fabienne ANJUERE and PhD Véronique BRAUD.
The research results expect to allow the identification of cellular and molecular mechanism that are involved in the development of skin cancer lesions and offer new approaches of immunotherapy against this type of cancer.


Yasmine TOUIL

2010 prize-winner: Yasmine TOUIL

Ph.D in pharmacology/cancerology
The research project of the laboratory is entitled "role of inflammatory factors in the activation of melanoma tumor stem cells. Therapeutic implications"..
The research work is conducted in the molecular and cellular targeting for cancer treatment group of the INSERM U837 Unit, at the Jean-Pierre Aubert centre in Lille, under the supervision of Renata POLAKOWSKA.
The work is aimed to provide knowledge about melanoma and open the way to new therapeutic approaches.


Caroline ASPORD

2009 prize-winner: Caroline ASPORD

Ph.D in Immunology and associate professor of biochemistry and biological engineering
The TherapDC project consists in understanding the role of pDCs in the development and control of melanoma in order to define new anti-tumor therapeutic strategies.
The research work is realized at the EFS/INSERM U823 R&D laboratory, in the cancer immunobiology and immunotherapy unit, under the direction of Doctor Joël PLUMAS.
The project, conducted in close collaboration with the dermatology department of Grenoble university hospital, should lead to better knowledge of the immunology of melanoma, enabling new therapeutic targets to be defined, and to the transfer of an innovative cell therapy protocol highly-promising.


Juan GARCÍA VALERO

2008 prize-winner: Juan GARCÍA VALERO

The research project is intituled: "Study of the mechanism of insertion membrane proteins of the family Bcl-2 and conception of poropeptides© anti-cancer / anti-angiogenic". It is called POROS (from the Greek ΠΟΡΟΣ and means, in the figurative sense, an effective way to by pass a difficulty).
The research work were conducted under the scientific supervision of the Dr. A. AOUACHERIA, researcher at the CNRS, at the "Institut de Biologie et de Chimie des Protéines" of Lyon within the team «Apoptose et Oncogenèse» headed by Pr. G. GILLET.
This project appear to open up highly promising paths of research in the field of cutaneous carcinogenesis.